Susquehanna International Group
TLSI icon

Susquehanna International Group’s TriSalus Life Sciences TLSI Stock Holding History

Susquehanna International Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52K Buy
+12,994
New +$63.6K ﹤0.01% 12629
2025
Q3 		– Sell
-20,558
Closed -$112K – 13886
2025
Q2 		$112K Buy
+20,558
New +$110K ﹤0.01% 11715

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Susquehanna International Group's TLSI Position: Q1 2026 in Review

Susquehanna International Group opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 12,994 shares worth $52K. The stake represents ﹤0.01% of the portfolio and ranks #12629 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in TLSI as recently as Q2 2025.

Susquehanna International Group first reported a position in TLSI in Q2 2025 and has held it in 2 quarters since. The position peaked at $112K in Q2 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Susquehanna International Group held 12,994 shares of TriSalus Life Sciences worth $52K as of Q1 2026.
  • TriSalus Life Sciences was a new Susquehanna International Group position in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12629 holding.
  • Susquehanna International Group first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 2 quarters since.
  • Susquehanna International Group's TriSalus Life Sciences position peaked at $112K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.